Published in J Cancer Prev on March 01, 2014
Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers. Gut Liver (2016) 0.91
The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz) (2015) 0.81
Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery. Gut Liver (2016) 0.81
Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia. Endosc Int Open (2015) 0.77
Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Gastric Cancer (2015) 0.75
Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol (2006) 3.18
Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum (1994) 2.68
Gastric cancer in Korea. Gastric Cancer (2002) 2.17
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc (2011) 1.85
Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter (2011) 1.82
Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer (2006) 1.71
Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol (2009) 1.67
Molecular pathology of gastric carcinoma. Pathobiology (2011) 1.49
Disparities in gastric cancer outcomes among Asian ethnicities in the USA. Ann Surg Oncol (2009) 1.46
Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter (2011) 1.43
Epstein-Barr virus and gastric carcinoma. Pathol Int (2010) 1.37
Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma. Clin Cancer Res (2004) 1.33
Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS (2003) 1.33
Laparoscopic total gastrectomy with D2 lymphadenectomy for advanced gastric cancer. World J Surg (2012) 1.26
A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol (2006) 1.26
Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. Arch Surg (2009) 1.22
Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol (2003) 1.16
Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol (2009) 1.13
Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci (2006) 1.11
Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival. Hum Pathol (2008) 1.10
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci (2007) 1.07
Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Arch Surg (2009) 1.06
Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer (2010) 0.98
Microsatellite instability testing in Korean patients with colorectal cancer. Fam Cancer (2012) 0.97
Prevalence and clinicopathologic characteristics of gastric cardia cancer in South Korea. Helicobacter (2012) 0.94
Prognostic significance of Bcl-2 and p53 expression in gastric cancer. Int J Colorectal Dis (2003) 0.92
Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori. Br J Surg (1995) 0.88
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes Control (2008) 0.88
Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma. Gastric Cancer (2007) 0.86
Prognostic significance of p53 protein expression in early gastric cancer. Pathol Oncol Res (2010) 0.85
Helicobacter pylori-seronegative gastric carcinoma: a subset of gastric carcinoma with distinct clinicopathologic features. Hepatogastroenterology (1999) 0.85
Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors? Anticancer Res (2005) 0.83
Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study. Hepatogastroenterology (2004) 0.78
Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol (2013) 1.83
Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future. Intest Res (2015) 1.00
Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis. Intest Res (2015) 0.97
Novel risk stratification for recurrence after endoscopic resection of advanced colorectal adenoma. Gastrointest Endosc (2014) 0.96
Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease. J Neurogastroenterol Motil (2015) 0.96
Prediction of Tumor Recurrence in Patients with Non-Gastric Gastrointestinal Stromal Tumors Following Resection according to the Modified National Institutes of Health Criteria. Intest Res (2014) 0.92
Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea. Intest Res (2014) 0.88
[Clinical features of hepatic tuberculosis in biopsy-proven cases]. Korean J Hepatol (2009) 0.85
A Randomized Controlled Clinical Study Comparing the Diagnostic Accuracy of the Histologic Prediction for Colorectal Polyps Depending on the Use of Either Magnified or Nonmagnified Narrow Band Imaging. Clin Endosc (2015) 0.84
Analysis of Gastric Microbiota by Pyrosequencing: Minor Role of Bacteria Other Than Helicobacter pylori in the Gastric Carcinogenesis. Helicobacter (2016) 0.83
Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study. Gut Liver (2016) 0.81
Risk Factors for Metachronous Gastric Neoplasms in Patients Who Underwent Endoscopic Resection of a Gastric Neoplasm. Gut Liver (2016) 0.81
Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in Korea. J Neurogastroenterol Motil (2014) 0.80
Multiple Polypoid Angiodysplasia with Obscure Overt Bleeding. Clin Endosc (2016) 0.80
Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. Gut Liver (2016) 0.79
Characteristics and outcomes of endoscopically resected colorectal cancers that arose from sessile serrated adenomas and traditional serrated adenomas. Intest Res (2016) 0.77
Metronidazole-induced encephalopathy in a patient with Crohn's disease. Intest Res (2017) 0.75
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study. Gut Liver (2016) 0.75
Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis. Gut Liver (2017) 0.75
Matricellular Protein Periostin Mediates Intestinal Inflammation through the Activation of Nuclear Factor κB Signaling. PLoS One (2016) 0.75
Early versus late bedside endoscopy for gastrointestinal bleeding in critically ill patients. Korean J Intern Med (2017) 0.75
Clinical characteristics of primary gastric lymphoma detected during screening for gastric cancer in Korea. J Gastroenterol Hepatol (2016) 0.75
The Clinical Characteristics and Prognosis of Crohn's Disease in Korean Patients Showing Proximal Small Bowel Involvement: Results from the CONNECT Study. Gut Liver (2017) 0.75
Patients with perianal Crohn's disease have poor disease outcomes after primary bowel resection. J Gastroenterol Hepatol (2016) 0.75
Obstructive sleep apnea is associated with an increased risk of colorectal neoplasia. Gastrointest Endosc (2016) 0.75
Comparisons of Gut Microbiota Among Healthy Control, Patients With Conventional Adenoma, Sessile Serrated Adenoma, and Colorectal Cancer. J Cancer Prev (2017) 0.75
Helicobacter pylori Is Associated with miR-133a Expression through Promoter Methylation in Gastric Carcinogenesis. Gut Liver (2017) 0.75
Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers. PLoS One (2017) 0.75
Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea. Gut Liver (2017) 0.75
Risk factors for early metachronous tumor development after endoscopic resection for early gastric cancer. PLoS One (2017) 0.75
Balloon Expulsion Test Does Not Seem to Be Useful for Screening or Exclusion of Dyssynergic Defecation as a Single Test. J Neurogastroenterol Motil (2017) 0.75
Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development. Gut Liver (2017) 0.75
Nimbolide Inhibits Nuclear Factor-КB Pathway in Intestinal Epithelial Cells and Macrophages and Alleviates Experimental Colitis in Mice. Phytother Res (2016) 0.75